ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China flag China · Delayed Price · Currency is CNY
24.75
+0.83 (3.47%)
Last updated: Jul 16, 2025
33.14%
Market Cap4.43B
Revenue (ttm)308.55M
Net Income (ttm)-48.15M
Shares Out151.47M
EPS (ttm)-0.32
PE Ration/a
Forward PEn/a
Dividend0.20 (0.76%)
Ex-Dividend DateJul 10, 2025
Volume7,803,504
Average Volume5,637,779
Open23.50
Previous Close23.92
Day's Range23.50 - 24.95
52-Week Range16.50 - 25.90
Beta0.30
RSI84.79
Earnings DateAug 26, 2025

About ChengDa Pharmaceuticals

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers APIs; bulk drugs for urogenital, musculoskeletal system, and antineoplastic and immunomodulators; and drug intermediates for blood and hematopoietic organs, digestive tract and metabolism, and nervous system. The company was founded in 1980 and is based in Jiaxing, China. [Read more]

Sector Healthcare
Founded 1980
Employees 607
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301201
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.